Cargando…

Disease Models & Mechanisms helps move heart failure to heart success

Heart failure affects ∼64 million people worldwide, resulting in high morbidity, mortality and societal cost. Current treatment strategies are primarily geared at slowing the progression to an advanced disease state, but do not reverse or cure heart failure. A more comprehensive understanding of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooper, Kirsty, Hmeljak, Julija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150112/
https://www.ncbi.nlm.nih.gov/pubmed/35593431
http://dx.doi.org/10.1242/dmm.049634
_version_ 1784717355337646080
author Hooper, Kirsty
Hmeljak, Julija
author_facet Hooper, Kirsty
Hmeljak, Julija
author_sort Hooper, Kirsty
collection PubMed
description Heart failure affects ∼64 million people worldwide, resulting in high morbidity, mortality and societal cost. Current treatment strategies are primarily geared at slowing the progression to an advanced disease state, but do not reverse or cure heart failure. A more comprehensive understanding of the underlying biology and development of preclinical models of this heterogeneous group of disorders will improve diagnosis and treatment. Here, we summarise recent preclinical and translational research in this area published in Disease Models & Mechanisms. We also discuss how our Journal is propelling this field forward by launching a Special Issue and ongoing subject collection, ‘Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy’.
format Online
Article
Text
id pubmed-9150112
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-91501122022-05-31 Disease Models & Mechanisms helps move heart failure to heart success Hooper, Kirsty Hmeljak, Julija Dis Model Mech Editorial Heart failure affects ∼64 million people worldwide, resulting in high morbidity, mortality and societal cost. Current treatment strategies are primarily geared at slowing the progression to an advanced disease state, but do not reverse or cure heart failure. A more comprehensive understanding of the underlying biology and development of preclinical models of this heterogeneous group of disorders will improve diagnosis and treatment. Here, we summarise recent preclinical and translational research in this area published in Disease Models & Mechanisms. We also discuss how our Journal is propelling this field forward by launching a Special Issue and ongoing subject collection, ‘Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy’. The Company of Biologists Ltd 2022-05-20 /pmc/articles/PMC9150112/ /pubmed/35593431 http://dx.doi.org/10.1242/dmm.049634 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Editorial
Hooper, Kirsty
Hmeljak, Julija
Disease Models & Mechanisms helps move heart failure to heart success
title Disease Models & Mechanisms helps move heart failure to heart success
title_full Disease Models & Mechanisms helps move heart failure to heart success
title_fullStr Disease Models & Mechanisms helps move heart failure to heart success
title_full_unstemmed Disease Models & Mechanisms helps move heart failure to heart success
title_short Disease Models & Mechanisms helps move heart failure to heart success
title_sort disease models & mechanisms helps move heart failure to heart success
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150112/
https://www.ncbi.nlm.nih.gov/pubmed/35593431
http://dx.doi.org/10.1242/dmm.049634
work_keys_str_mv AT hooperkirsty diseasemodelsmechanismshelpsmoveheartfailuretoheartsuccess
AT hmeljakjulija diseasemodelsmechanismshelpsmoveheartfailuretoheartsuccess